Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Serum cholesterol, use of lipid-lowering drugs, and risk of Parkinson disease.

× No keyword cloud information.

11 in total

1. Statin use and Parkinson's disease in Denmark.

Authors: Beate Ritz; Angelika D Manthripragada; Lei Qian; Eva Schernhammer; Lene Wermuth; Jorgen Olsen; Soren Friis
Journal: Mov Disord Date: 2010-07-15 Impact factor: 10.338

2. Statin use and risk of Parkinson's disease: a meta-analysis of observational studies.

Authors: Krishna Undela; Kapil Gudala; Swathi Malla; Dipika Bansal
Journal: J Neurol Date: 2012-07-21 Impact factor: 4.849

3. Understanding the links between cardiovascular disease and Parkinson's disease.

Authors: Judy Potashkin; Xuemei Huang; Claudia Becker; Honglei Chen; Thomas Foltynie; Connie Marras
Journal: Mov Disord Date: 2019-09-04 Impact factor: 10.338

Review 4. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors in the treatment of central nervous system diseases.

Authors: Joshua Z Willey; Mitchell S V Elkind
Journal: Arch Neurol Date: 2010-09

5. Prospective study of statin use and risk of Parkinson disease.

Authors: Xiang Gao; Kelly C Simon; Michael A Schwarzschild; Alberto Ascherio
Journal: Arch Neurol Date: 2012-03

6. Association between Statin Use and Risk of Parkinson's Disease: Evidence from 18 Observational Studies Comprising 3.7 Million Individuals.

Authors: Chieh-Chen Wu; Md Mohaimenul Islam; An-Jen Lee; Chun-Hsien Su; Yung-Ching Weng; Chih-Yang Yeh; Hsun-Hua Lee; Ming-Chin Lin
Journal: J Pers Med Date: 2022-05-19

Serum cholesterol, use of lipid-lowering drugs, and risk of Parkinson disease.

1. Statin use and Parkinson's disease in Denmark.

2. Statin use and risk of Parkinson's disease: a meta-analysis of observational studies.

3. Understanding the links between cardiovascular disease and Parkinson's disease.

Review 4. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors in the treatment of central nervous system diseases.

5. Prospective study of statin use and risk of Parkinson disease.

6. Association between Statin Use and Risk of Parkinson's Disease: Evidence from 18 Observational Studies Comprising 3.7 Million Individuals.

7. Statin Use and the Risk of Parkinson's Disease: An Updated Meta-Analysis.

8. Statin adherence and the risk of Parkinson's disease: A population-based cohort study.

9. Heart rate, intelligence in adolescence, and Parkinson's disease later in life.

10. Circulating Cholesterol Levels May Link to the Factors Influencing Parkinson's Risk.